These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8651595)

  • 1. NDF/heregulins stimulate expression of the erbB-2 tyrosine kinase growth factor receptor gene in human breast cancer cells.
    Maggiora P; De Bortoli M
    Ann N Y Acad Sci; 1996 Apr; 784():443-7. PubMed ID: 8651595
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of aroclors and DDT on growth factor gene expression and receptor tyrosine kinase activity in human breast epithelial cells.
    Shen K; Novak RF
    Adv Exp Med Biol; 1997; 407():295-302. PubMed ID: 9321967
    [No Abstract]   [Full Text] [Related]  

  • 3. Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland.
    Bates NP; Hurst HC
    J Mammary Gland Biol Neoplasia; 1997 Apr; 2(2):153-63. PubMed ID: 10882301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal regulation of type I receptor tyrosine kinase expression in the mammary gland.
    De Bortoli M; Dati C
    J Mammary Gland Biol Neoplasia; 1997 Apr; 2(2):175-85. PubMed ID: 10882303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
    Karunagaran D; Tzahar E; Beerli RR; Chen X; Graus-Porta D; Ratzkin BJ; Seger R; Hynes NE; Yarden Y
    EMBO J; 1996 Jan; 15(2):254-64. PubMed ID: 8617201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells.
    Bacus SS; Yarden Y; Oren M; Chin DM; Lyass L; Zelnick CR; Kazarov A; Toyofuku W; Gray-Bablin J; Beerli RR; Hynes NE; Nikiforov M; Haffner R; Gudkov A; Keyomarsi K
    Oncogene; 1996 Jun; 12(12):2535-47. PubMed ID: 8700512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
    Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.
    Marte BM; Jeschke M; Graus-Porta D; Taverna D; Hofer P; Groner B; Yarden Y; Hynes NE
    Mol Endocrinol; 1995 Jan; 9(1):14-23. PubMed ID: 7760847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.
    Beerli RR; Graus-Porta D; Woods-Cook K; Chen X; Yarden Y; Hynes NE
    Mol Cell Biol; 1995 Dec; 15(12):6496-505. PubMed ID: 8524214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells.
    Ram TG; Kokeny KE; Dilts CA; Ethier SP
    J Cell Physiol; 1995 Jun; 163(3):589-96. PubMed ID: 7775601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP; Kokeny KE; Ridings JW; Dilts CA
    Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heregulins and the ErbB-2/3/4 receptors in gliomas.
    Westphal M; Meima L; Szonyi E; Lofgren J; Meissner H; Hamel W; Nikolics K; Sliwkowski MX
    J Neurooncol; 1997 Dec; 35(3):335-46. PubMed ID: 9440030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ErbB kinases and NDF signaling in human prostate cancer cells.
    Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
    Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neu differentiation factor inhibits EGF binding. A model for trans-regulation within the ErbB family of receptor tyrosine kinases.
    Karunagaran D; Tzahar E; Liu N; Wen D; Yarden Y
    J Biol Chem; 1995 Apr; 270(17):9982-90. PubMed ID: 7730382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells.
    Daly JM; Jannot CB; Beerli RR; Graus-Porta D; Maurer FG; Hynes NE
    Cancer Res; 1997 Sep; 57(17):3804-11. PubMed ID: 9288791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein.
    Kim HH; Vijapurkar U; Hellyer NJ; Bravo D; Koland JG
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):189-95. PubMed ID: 9693119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes.
    Marikovsky M; Lavi S; Pinkas-Kramarski R; Karunagaran D; Liu N; Wen D; Yarden Y
    Oncogene; 1995 Apr; 10(7):1403-11. PubMed ID: 7731691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NDF/heregulin stimulates the phosphorylation of Her3/erbB3.
    Kita YA; Barff J; Luo Y; Wen D; Brankow D; Hu S; Liu N; Prigent SA; Gullick WJ; Nicolson M
    FEBS Lett; 1994 Jul; 349(1):139-43. PubMed ID: 8045292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2.
    Zhang K; Sun J; Liu N; Wen D; Chang D; Thomason A; Yoshinaga SK
    J Biol Chem; 1996 Feb; 271(7):3884-90. PubMed ID: 8632008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.